Skip to main content

Rehabilitation and palliation of ovarian cancer patients

  • Chapter
  • 781 Accesses

Part of the Collection de L’Académie Européenne de Médecine de Réadaptation book series (LACADEMIE)

Abstract

The chief aim of all medical, potentially curative follow-up care measures (recurrence prevention, early detection and therapy of disease recurrence) is to lengthen survival time (fig. 1.1). The cancer disease thus represents the focus of curative follow-up care.

Keywords

  • Ovarian Cancer
  • Bowel Obstruction
  • Ovarian Carcinoma
  • Ovarian Cancer Patient
  • Short Bowel Syndrome

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-2-287-72827-3_7
  • Chapter length: 28 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   219.00
Price excludes VAT (USA)
  • ISBN: 978-2-287-72827-3
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   279.99
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • — Antoniou, Pharoah AP, Narodet S et al. (2003) Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies.. Am J Hum Genet 72: 1117–30

    PubMed  CrossRef  CAS  Google Scholar 

  • — Aspinal F, Hughes R, Higginson I et al. (2002) A user’s guide to the palliative care outcome scale. Palliative care & policy publications. Kings College, London

    Google Scholar 

  • — Barat M, Franchignoni F (2004) Assessment in physical medicine and rehabilitation. Maugeri Foundation books PI-ME Press Pavia

    Google Scholar 

  • — Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62

    PubMed  CrossRef  Google Scholar 

  • — Bingham S, Riboli E (2004) Diet and Cancer. The European Prospective Investigation in Cancer and Nutrition. Nat Rev Cancer 4(3): 206–15

    PubMed  CrossRef  CAS  Google Scholar 

  • — Becker G, Galandi D, Blum HE (2006) Malignant ascites: Systematic review and guideline for treatment. Eur J Cancer 42: 589–97

    PubMed  CrossRef  Google Scholar 

  • — Bundesarbeitsgemeinschaft für Rehabilitation (2003) Rahmenempfehlungen zur ambulanten onkologischen Rehabilitation. Schriftenreihe der Bundesarbeitsgemeinschaft für Rehabilitation (BAR), Frankfurt

    Google Scholar 

  • — Carmack Taylor C (2004) Predictors of sexual functioning in ovarian cancer patients, J Clin Oncol 22: 881–9

    PubMed  CrossRef  Google Scholar 

  • — Chanan-Khan A, Srinivasan S, Czucman M (2004) Prevention and management of cardiotoxicity from antineoplastic therapy. J Support Oncol 2: 251–66

    PubMed  Google Scholar 

  • — Classe JM, Catala L, Marchal F et al. (2004) Locoregional recurrence of ovarian cancer: The place of surgery. Bull Cancer 91,11: 827–32

    PubMed  Google Scholar 

  • — Covey A (2005) Management of malignant pleural effusions and ascites. J Support Oncol 3: 169–76

    PubMed  Google Scholar 

  • — Dunton JC (2002) Management of treatment-related toxicity in advanced ovarian cancer. Oncologist 7: 11–9

    PubMed  CrossRef  CAS  Google Scholar 

  • — Doyle C, Crump M, Pintilie M et al. (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer

    Google Scholar 

  • — Dubois A, Schlaich M et al. (1999) Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care cancer 7: 354

    CrossRef  CAS  Google Scholar 

  • — Faries MB, Romeau JL (1999) Use of gastrostomy-and combined gastrojejunostomy tubes for enteral feeding. World J Surg 23: 603–7

    PubMed  CrossRef  CAS  Google Scholar 

  • — Gore M (2001) Relapses epithelial ovarian cancer. ASCO educational book 37th annual meeting, 2001, 468–76

    Google Scholar 

  • — Grueningen van V, Daly B (2005) Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 97: 638–44

    CrossRef  Google Scholar 

  • — IARC (2003) Handbook of cancer prevention, No 8: Fruits and vegetables. International Agency for Research on Cancer (IARC-WHO)

    Google Scholar 

  • — Jatoi A, Windschitl H, Loprinzi C et al. (2002) Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia. J Clin Oncol, 20,2: 567–73

    PubMed  CrossRef  CAS  Google Scholar 

  • — Jatoi A, Podratz KC et al. (2004) Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol 2: 323–37

    PubMed  Google Scholar 

  • — Junker A, Kretschmar A, Bohm U et al. (2004) Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis. Med. Monatsschr Pharm 27,10: 349–52

    PubMed  Google Scholar 

  • — Kuschel B, Lux M, Goecke T et al. (2000) Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer. European Journal of Cancer Prevention 9,3: 139–50

    PubMed  CrossRef  CAS  Google Scholar 

  • — Langseth H, Kjaerheim K (2004) Ovarian cancer and occupational exposure among pulp and paper employees in Norway. Scand J Work Environ Health 30,5: 356–61

    PubMed  Google Scholar 

  • — Ledermann JA, Wheeler S (2004) How should we manage patients with “platinum sensitive” recurrent ovarian cancer? Cancer Invest 22,2: 2–10

    PubMed  CrossRef  CAS  Google Scholar 

  • — Levy MH, Cohen SD (2005) Sedation for the relief of refractory symptoms in the imminently dying: A fine intentional line. Semin Oncol 32: 237–46

    PubMed  CrossRef  Google Scholar 

  • — Lim JF, Ho YH (2001) Total colectomy with ileorectal anastomosis leads to appreciable loss in quality of life. Techniques in coloproctology 5,2: 79–83

    PubMed  CrossRef  CAS  Google Scholar 

  • — Mielke S, Sparreboom A, Mross K (2006) Peripheral neuropathy: A persisting challenge in paclitaxel-based regimens. Eur J Cancer 42: 24–30

    PubMed  CrossRef  CAS  Google Scholar 

  • — Norton TR, Manne SL, Rubin S et al. (2004) Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol 1,22, 5: 919–26

    CrossRef  Google Scholar 

  • — Parsons SL, Lang M, Steele R (1996) Malignant ascites. Eur J Surg Oncol 22: 237–9

    PubMed  CrossRef  CAS  Google Scholar 

  • — Paice J (2003) Mechanisms and mamagement of neuropathic pain in cancer. J support Oncol 1,2: 107–14

    PubMed  Google Scholar 

  • — Pothuri B, Guirguis A, Gerdes H et al. (2004) The use of colorectal stents for palliation of large bowel obstruction due to recurrent gynaecologic cancer. Gynecol Oncol 95(3): 513–7

    PubMed  CrossRef  Google Scholar 

  • — Pothuri B, Meyer L, Gerardi M et al. (2004) Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecol Oncol 95,1: 193–5

    PubMed  CrossRef  Google Scholar 

  • — Schover L (2005) Sexuality and fertility after cancer. The American society of Hematology

    Google Scholar 

  • — Sood AK, Lush R, Geisler JP et al. (2004) Sequential intraperitoneal topotecan and oral chemotherapy in recurrent platinum-resistant ovarian carcinoma. Clin Cancer Res 15,10:6080–5

    CrossRef  Google Scholar 

  • — Stewart D, Cheung A, Dancey J et al. (2000) Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol 77,3: 357–61

    PubMed  CrossRef  CAS  Google Scholar 

  • — Sun C, Ramirez P, Bodurka D (2007) Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol 4,1: 18–29

    PubMed  CrossRef  Google Scholar 

  • — Vadaparampil ST, Wey JP, Kinney AY (2004) Psychosocial aspects of genetic counselling and testing. Semin Oncol Nurs 20,3: 186–95

    PubMed  CrossRef  Google Scholar 

  • — Wan GJ, Counte MA, Cella DF (1997) The influence of personal expectations on cancer patients’ reports of health related quality of life. Psycho-oncology 6: 1–11

    PubMed  CrossRef  CAS  Google Scholar 

  • — Watson M, Forster C, Eccles D et al. (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a genetic testing in a U.K. multi-centre clinical cohort.

    Google Scholar 

  • — Watson T, Mock V (2004) Exercise as an intervention for cancer related fatigue. Phys Ther 84: 736–43

    PubMed  Google Scholar 

  • — World Health Organization (2001) International classification of functioning, disabilities and health. www. who.int/classification/ICF

    Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

(2007). Rehabilitation and palliation of ovarian cancer patients. In: Rehabilitation and palliation of cancer patients. Collection de L’Académie Européenne de Médecine de Réadaptation. Springer, Paris. https://doi.org/10.1007/978-2-287-72827-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72827-3_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72826-6

  • Online ISBN: 978-2-287-72827-3

  • eBook Packages: MedicineMedicine (R0)